CLERICO, ALDO
 Distribuzione geografica
Continente #
AS - Asia 1.510
NA - Nord America 1.153
EU - Europa 1.018
SA - Sud America 268
AF - Africa 37
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.991
Nazione #
US - Stati Uniti d'America 1.089
IT - Italia 722
SG - Singapore 623
CN - Cina 364
BR - Brasile 216
HK - Hong Kong 143
VN - Vietnam 141
NL - Olanda 104
FR - Francia 71
BD - Bangladesh 63
KR - Corea 56
CA - Canada 30
DE - Germania 27
GB - Regno Unito 24
IN - India 24
AR - Argentina 22
JP - Giappone 20
FI - Finlandia 16
EC - Ecuador 12
MX - Messico 12
ID - Indonesia 11
IL - Israele 9
TR - Turchia 9
ZA - Sudafrica 9
JM - Giamaica 7
MA - Marocco 7
IQ - Iraq 6
PL - Polonia 6
CO - Colombia 5
ES - Italia 5
PH - Filippine 5
PK - Pakistan 5
UA - Ucraina 5
ET - Etiopia 4
HU - Ungheria 4
KE - Kenya 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
SE - Svezia 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
DZ - Algeria 3
HN - Honduras 3
IE - Irlanda 3
KZ - Kazakistan 3
LB - Libano 3
SM - San Marino 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BE - Belgio 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
JO - Giordania 2
MY - Malesia 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
CV - Capo Verde 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HT - Haiti 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PF - Polinesia Francese 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.991
Città #
Singapore 374
Santa Clara 350
Hong Kong 139
Hefei 126
Beijing 100
Rome 73
San Jose 72
Ashburn 70
Lauterbourg 60
Seoul 55
Milan 48
Hanoi 44
Los Angeles 44
Ho Chi Minh City 42
New York 26
Naples 25
Florence 24
Buffalo 20
São Paulo 19
Atlanta 16
Bologna 16
Helsinki 16
Bari 15
Modena 14
Turin 14
Dallas 11
Denver 11
Frankfurt am Main 11
Palermo 11
Falkenstein 10
Genoa 10
Belo Horizonte 9
Orem 9
Minamishinagawa 8
Montreal 8
Padua 8
Curitiba 7
Da Nang 7
Houston 7
Messina 7
Rio de Janeiro 7
Bengaluru 6
Council Bluffs 6
Monza 6
Perugia 6
Salvador 6
Tokyo 6
Brooklyn 5
Buenos Aires 5
Chennai 5
Chicago 5
Osaka 5
Solza 5
Toronto 5
Warsaw 5
Ankara 4
Bollate 4
Brasília 4
Elk Grove Village 4
Guangzhou 4
Kingston 4
London 4
Macerata 4
Martinengo 4
Milwaukee 4
New Delhi 4
Newark 4
Ninh Bình 4
Phoenix 4
Quito 4
Stockholm 4
Thái Bình 4
Addis Ababa 3
Baghdad 3
Baku 3
Betim 3
Bolzano 3
Boston 3
Bridgetown 3
Bắc Giang 3
Cagliari 3
Cao Lanh 3
Cascina 3
Catania 3
Changsha 3
Delhi 3
Düsseldorf 3
Guayaquil 3
Haiphong 3
Hải Dương 3
Johannesburg 3
La Paz 3
Londrina 3
Manchester 3
Montevideo 3
Nairobi 3
Novate Milanese 3
Paternò 3
Rabat 3
Reggio Emilia 3
Totale 2.171
Nome #
CONTROLLO DI QUALITÀ IN MEDICINA DI LABORATORIO: STATO DELL'ARTE E POSSIBILI INNOVAZIONI 976
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure 79
Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients. 77
Atrial (ANP) and Brain (BNP) Natriuretic Peptides, Endothelin and ET binding sites in human heart failure 72
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients 70
Aerobic training decrease B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. 67
Granulocyte- and monocyte-platelet adhesion index in coronary and peripheral blood after extracorporeal circulation and reperfusion 65
Endothelin-1, Endothelin-1receptors and cardiac natriuretic peptides in human failing heart 64
Cardiac natriuretic hormones: methodological aspects 63
Evaluation of the endocrine function of the heart in humans: proposal for an integrated approach for the assessment of production, secretion, distribution and degradation of atrial natriuretic factor and related peptides 57
Livelli plasmatici dei peptidi natriuretici cardiaci (ANP e BNP) nei pazienti uremici in emodialisi cronica. 57
Stato dell'arte della misura degli ormoni tiroidei liberi come evidenziato dal Controllo di Qualità Esterno 56
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretis peptide in humans 54
Analytical performance and diagnostic accuracy of immunometricassays for the measurement of plasma BNP and NT-proBNP concentrations. 54
SERCA2a, Phospholamban, Sarcolipin, and Ryanodine Receptors Gene Expression in Children with Congenital Heart Defects 53
Low triiodothyronine and exercise capacity in heart failure 52
Evaluation of reproducibility of the cTnT immunoassay using quality control samples 51
Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle. 51
Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia 50
Evidence that atrial natriuretic peptide tissue extraction is not changed by large increases in its plasma levels induced by pacing in humans 50
Determination of endothelin binding sites in bovine atrial and ventricular membranes: a model for binding studies in human cardiac tissue 49
Determinazione dei peptidi natriuretici cardiaci (ANP,BNP,E PEPTIDI CORRELATI):caratteristiche analitiche ed utilità clinica 49
Multicentre comparison of BNP andNT-proBNP immunoassays: the CardioOrmocheck study 49
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 48
Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation 47
Atrial Natriuretic peptide is not degraded by the lungs in humans 47
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay 46
Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone 45
Prognostic Value of Combined Measurement of Brain Natriuretic Peptide and Triiodothyronine in Heart Failure 44
Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice 44
C-type natriuretic peptide plasma levels and whole blood mrna expression show different trends in adolescents with different degree of endothelial dysfunction 44
Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. 42
Importanza dei metodi di dosaggio dei peptidi cardiaci natriuretici (ANP e BNP) nella valutazione clinica dei pazienti con scompenso cardiaco. 41
Harmonization of free thyroid hormone tests: a mission impossible? 40
Laboratory evaluation of inflammatory reaction following percutaneous transluminal coronary angioplasty (PTCA). 39
Cardiac natriuretic hormone system as a target for cardiovascular therapy 39
The humoral, renal and pressor effects of systemic L-arginine infusion in hypertensive patients. 39
Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure 38
Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: The need for a new generation of immunoassay methods 37
Preparation of mono-radio-iodinated tracers for kinetic studies of cardiac natriuretic peptide in humans. 36
Osteopontin and interleukin-6 as markers of restenosis after coronary angioplasty? 36
Plasmatic Levels Of Cardiac Natriuretic Hormones In Healthy Adults: Effects Of Age And Sex. 36
Evaluation of Analytical Performance of the Siemens ADVIA TnI Ultra Immunoassay. 36
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training 35
Thyroid Function and Cardiac Surgery: What Should We Measure, and When? 34
Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. 34
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. 34
Preparazione di endotelina radiomarcata per studi di legame su tessuto cardiaco. 32
Endothelin-1, endothelin-1 receptors and cardiac natriuretic peptides in failing human heart 32
Imaging and laboratory biomarkers in cardiovascular disease 31
Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298-->Asp and T-786-->C polymorphisms. 30
Livelli plasmatici di adrenomedullina in pazienti con insufficienza renale prima e dopo emodialisi. 29
Influence of gender on circulating cardiac natriuretic hormones in patients heart failure 29
125-I-Endothelin-1 binding sites in human cardiac tissue 28
Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones. 28
Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure 28
Determinazione dei siti di legame dell'endotelina su membrane di atrio e di ventricolo bovino: un modello per studi di legame su tessuto cardiaco umano 28
Endothelin binding sites in human cardiac tissue from pediatric patients. 28
Effects of different anti-aging dietary restrictions on endothelin-1 receptors in rat lung 27
Analitical characteristics and clinical usefulness of an Irma for Brain Natriuretic Peptide (BNP) in plasma samples and cardiac tissue extracts. 27
Atrial (ANP) and Brain (BNP) Natriuretic Peptides, Endothelin and ET binding sites in human heart failure 27
Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared. 26
Sviluppo di un metodo analitico per la separazione e la misura delle isoforme dell'endotelina in campioni biologici umani. 26
Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method. 25
Determination of endothelin binding sites in bovine atrium and ventricle membranes: a model for binding studies in human cardiac tissue. 25
Determination of N-terminal pro-ANP in plasma and cardiac tissue extracts: comparison of competitive and non-competitive immunoassays. 25
Methodological implications and clinical usefulness of IRMA methods for the measurement of natriuretic cardiac peptides. 25
Atrial natriuretic peptide (ANP) binding sites on human platelets: an useful tool to evaluate the regulation of ANP receptors in humans 25
Plasma levels of atrial and brain natriuretic peptide in patients with renal insufficiency. 24
Methodological assessment of HPLC separation of endothelin (ET) isoforms in human biological samples 23
Plasma levels of Atrial Natriuretic Peptide (ANP), Brain Natriuretic Peptide (BNP) and N-terminal fragment of Pro-ANP in Heart Failure and in controls. 21
[Physiological significance and clinical utility of analytical methods for cardiac natriuretic peptides]. 20
Measurement of N-Terminal fragment of Proatrial Natriuretic peptide in Human Plasma by a new immunoradiometric assay: relationship with atrial and brain natriuretic peptides. 20
Immunoassay methods for the measurement of natriuretic cardiac Hormones - ANP, BNP, and related peptides - in humans 18
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure 17
Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. 17
Endothelin and cardiac natriuretic peptides in heart failure. 16
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides. 14
Totale 3.997
Categoria #
all - tutte 10.854
article - articoli 8.920
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 380
Totale 20.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202416 0 0 0 0 0 0 0 0 1 0 7 8
2024/20251.315 2 7 108 56 291 93 32 50 55 77 275 269
2025/20262.588 125 197 173 336 492 141 264 130 134 176 149 271
2026/202778 78 0 0 0 0 0 0 0 0 0 0 0
Totale 3.997